eCORE
- Cancer
- Personalized Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health
Team
Group Leader
Coro Bescós Atín
Principal Investigator (PI)
Coro Bescós Atín, Jorge Pamias Romero, Montserrat Munill Ferrer, Alba de Pablo García-Cuenca
Researchers
Manel Sáez Barba, Vicenç Juan Gómez, Iago Álvarez Sáez, Adriana Agell Sogbe
PhD Students
Pablo Vaquero Martínez, Ingrid Guarro Marzoa, Pau Rofín, Álvaro Bretons
Nursing and Technical Staff
Rosa Pujol Pina
Publications
Hernando-Calvo A, Mirallas O, Marmolejo D, et al.
Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients.
Oral Oncol. 2023;140:106364.
DOI: 10.1016/j.oraloncology.2023.106364
IF: 1.497
de la Fuente C, Prat-Valero N, Alberola-Ferranti M, et al.
Occult metastases of oral maxillary squamous cell carcinoma: Systematic review and meta-analysis
Head Neck 2023;45(3):733-744
DOI: 10.1002/hed.27276
IF: 2.9
Masià-Gridilla J, Gutiérrez-Santamaría J, Álvarez-Sáez I, Pamias-Romero J, Saez-Barba M, Bescós-Atin C.
Outcomes Following Autologous Fat Grafting in Patients with Sequelae of Head and Neck Cancer Treatment.
Cancers (Basel). 2023;15(3):800.
DOI: 10.3390/cancers15030800
IF: 5.2
Pamias-Romero J, Saez-Barba M, de-Pablo-García-Cuenca A, Vaquero-Martínez P, Masnou-Pratdesaba J, Bescós-Atín C.
Quality of Life after Mandibular Reconstruction Using Free Fibula Flap and Customized Plates: A Case Series and Comparison with the Literature.
Cancers (Basel). 2023;15(9):2582.
DOI: 10.3390/cancers15092582
IF: 5.2
Vaquero Martinez P, Guarro Marzoa I, de Pablo Cuenca-Garcia A, Bescos Atin C.
Unilateral hard palate necrosis following gingival injections with hyaluronic acid.
BMJ Case Rep. 2023;16(2):e254599
DOI: 10.1136/bcr-2023-254599
IF: N/A
Projects
Compra Pública de Innovación “SA51-006903” titulado “3D-LAB – Servei de Cirurgia Personalitzada”. Fons europeu de desenvolupament regional Catalunya 2014-2020 (PO FEDER Catalunya 2014-020).
Principal Investigator: Coro Bescós Atín / Jordi Pamias Romero
Agency: Fons Europeu de Desenvolupament Regional Catalunya
Funding: 1,997,905€
Period: 2019-2023
INTERCEPT (INTercEption of oRal CancEr development) COST Action – Addressing the challenge of unmet oral cancer prevention and bringing new paradigm to disease management of oral potentially malignant disorders (OPMD
Principal Investigator: N/A
Agency: EU Cost Action
Funding: No funding
Period: 2022 - ongoing
Screening mediante citología de lesiones orales en pacientes con Anemia de Fanconi (AF)
Principal Investigator: Alba de Pablo García-Cuenca
Agency: N/A
Funding: No funding
Period: In process
METWASTE2: How Metastatic Tumours Drive Energy Wasting Syndrome – H&N Tumours
Principal Investigator: N/A
Agency: N/A
Funding: No funding
Period: In process